Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Darden Restaurants, Inc. (DRI): Can This Restaurant Stock Turn Around Disappointing Sales?

Unless you’re a restaurant critic for a local paper in a small North Dakota town, Olive Garden is just another worn out restaurant concept that’s lasted far too long on free breadsticks, thin soups, and salads swimming in Italian dressing.

For a long time Darden Restaurants, Inc. (NYSE:DRI)‘s bread and butter was the casual customer. Olive Garden and Red Lobster concepts were the only places in between high-quality dining and mom and pop burger shops. They were neither expensive nor places of fine dining; they are restaurants of the middle class.

Recently, though, the fast casual concept seems to have taken steam from these two well-known names. Companies like Panera Bread (NASDAQ:PNRA), and Chipotle Mexican Grill (NYSE:CMG) are a step up from a burger, but not a place where you’ll have to relearn what to do with a napkin upon sitting down.

Darden Restaurants, Inc. (NYSE:DRI)How Darden plans to compete

A new menu at Olive Garden should help the brand reconnect with lost customers. It will focus on inexpensive meals and items with a lower calorie count, something not so easy with carb-heavy pasta meals.

Darden Restaurants, Inc. (NYSE:DRI) recognizes the need to work with a desire for a faster-paced experience. Chains like Panera Bread offer reasonably healthy choices at lower prices and at a pace the customer can choose. Olive Garden’s sit-down approach may have to cut a few corners to make compromises.

While Darden may be down, it certainly isn’t out. The company acquired a chain of restaurants known as Yard House in 2012, which the company hopes will present it with more growth opportunities in the future. Meanwhile, the company is also adding LongHorn Steakhouses and Bahama Breeze locations to its list of successful restaurants. Darden Restaurants, Inc. (NYSE:DRI) opened 32 new LongHorn Steakhouses in just the past year to up the concept’s current total to 399 locations.

A value among other players

Investors seem to discount Darden Restaurants, Inc. (NYSE:DRI)’s long-run potential for fixable problems at the flagship store Olive Garden. Yard House is an impressive growth story for the company, as it plans to grow the brand from 40 to 200 locations. The beer and spirits-centric operation that hauls in average revenue of $20.43 per person will be consistent with Darden’s love of high operating margin restaurants.

All in, Darden will undoubtedly grow slower than Chipotle Mexican Grill or Panera Bread, but on a relative valuation basis, the company looks cheap. Darden Restaurants trades at 12 times forward earnings estimates compared to 20 times for Panera Bread and 25 times for Chipotle Mexican Grill.

Leverage differentials make Darden Restaurants, Inc. (NYSE:DRI) an even better value. It posts nearly identical returns on shareholder equity yet trades at only three times book value compared to Panera’s 6 times book value and Chipotle’s 8 times book value.

Darden’s a value investor’s pick. While Olive Garden is an aging concept, it’s a consistent concept. Furthermore, up and coming concepts like Yard House presents Darden shareholders with a case for continued earnings growth. And let’s not forget that while Darden may have hit a low point recently, the company still owns some of the best known brands in the space – brands now trading at a discount for all the opportunity in front of them.

The article Can This Restaurant Stock Turn Around Disappointing Sales? originally appeared on

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!